|
During the next twelve months,
Pediatric Pharmaceuticals, Inc. (PPI) Plans to conduct a
number of clinical trials. Specifically, we are planning the
following collaborations:
-The University of Chicago Medical Center
(investigational drug)
-The University of
Minnesota (nutraceutical)
-The University of Florida
(investigational drug)
-Colorado State University
(investigational drug)
In addition to the above, we are in
preliminary discussions with Kansas State University and
Rutgers University about possible clinical trials. We are also
discussing two collaborations with other pharmaceutical
companies, which could lead to clinical trials.
We are planning to file or license a
number of patents, which would protect our future operations.
These patents would primarily be for unique products or
combination of products that show greater efficacy than
existing drugs. We have found that the extensive use of
consultants and contract services has enabled us to perform at
a very efficient pace.
| 
